Providence Medical Technology Announces Presentation of Two-Year Outcomes of Posterior Cervical Fusion for Single-Level Cervical Radiculopathy - Providence Medical Technology, Inc.

Providence Medical Technology, Inc., an innovator in tissue-sparing cervical spine technology, today announced the closing of $12 million in new financing for the company. The proceeds will be used to further commercialize and expand its portfolio of DTRAX® cervical fusion products designed to help patients suffering from cervical degenerative disc disease.

Team | Innovation | Quality | Passion | Transparency
Copyright © 2024, Providence Medical Technology. All rights reserved.